1. Home
  2. GPK vs PBLS Comparison

GPK vs PBLS Comparison

Compare GPK & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

HOLD

Current Price

$11.02

Market Cap

3.0B

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.28

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPK
PBLS
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.6B
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
GPK
PBLS
Price
$11.02
$31.28
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$13.08
N/A
AVG Volume (30 Days)
4.0M
502.7K
Earning Date
05-05-2026
N/A
Dividend Yield
4.58%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,617,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.79
$25.56
52 Week High
$23.76
$33.65

Technical Indicators

Market Signals
Indicator
GPK
PBLS
Relative Strength Index (RSI) 57.18 56.52
Support Level $9.95 $26.83
Resistance Level $11.31 $33.65
Average True Range (ATR) 0.40 2.62
MACD 0.06 0.14
Stochastic Oscillator 80.61 63.76

Price Performance

Historical Comparison
GPK
PBLS

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: